Publications authored by CHSPR faculty and staff from 2009 to the present are listed here. Older peer-reviewed publications are usually available from individual journals and can be searched for using PubMed. Older reports published by CHSPR (from 1973) are available from the UBC Library cIRcle database. If you cannot find a specific publication, please contact us.
Johnson KM, Cheng L, Yin Y, Carter R, Chow S, Brigham E, Law MR. The Impact of Eliminating Out-of-Pocket Payments on Asthma Medication Use. Ann Am Thorac Soc. 2024 Aug 6. doi: 10.1513/AnnalsATS.202402-130OC. Online ahead of print. Read more
Law M, Clement F. National Pharmacare: Laying the Groundwork. IRPP Insight No. 51. Montreal: Institute for Research on Public Policy; February 2024. Read more
Johnson KM, Cheng L, Yin Y, Carter R, Chow S, Brigham E, Law MR. Impact of income-based public drug coverage deductibles on adherence to asthma medications. Ann Allergy Asthma Immunol. 2023 Oct 21:S1081-1206(23)01345-5. doi: 10.1016/j.anai.2023.10.017. Online ahead of print. Read more
Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Wu F, Laupacis A; CLEAN Meds study team. Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial. JAMA Health Forum. 2023 May 5;4(5):e231127. doi: 10.1001/jamahealthforum.2023.1127. Read more
Nethery E, Hutcheon JA, Law MR, Janssen PA. Validation of Insurance Billing Codes for Monitoring Antenatal Screening. Epidemiology. 2023 Mar 1;34(2):265-270. doi: 10.1097/EDE.0000000000001569. Epub 2022 Nov 29. Read more
Miregwa BN, Holbrook A, Law MR, Lavis JN, Thabane L, Dolovich L, Wilson MG. The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis. CMAJ Open. 2022 Sep 27;10(3):E848-E855. doi: 10.9778/cmajo.20210295. Read more
Hofmeister M, Sivakumar A, Clement F, Hayes KN, Law M, Guertin JR, Neville HL, Tadrous M. Trends in Canadian prescription drug purchasing: 2001-2020. J Pharm Policy Pract. 2022 Mar 17;15(1):20. doi: 10.1186/s40545-022-00420-4. Read more
Alves JC, Law MR, Luz TCB. Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project. Value Health Reg Issues. 2022 Mar 17;30:83-90. doi: 10.1016/j.vhri.2022.01.006. Online ahead of print. Read more
Ho H, Janjua NZ, McGrail KM, Harrison M; BC Hepatitis Testers Cohort Team, Law MR. The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia. PLoS One. 2021 Mar 1;16(3):e0247843. Read more
Contandriopoulos D, Law MR. Policy changes and physicians opting out from Medicare in Quebec: an interrupted time-series analysis. CMAJ. 2021 Feb 16;193(7):E237-E241. Read more
Daw JR, Law MR. Compared With Other Countries, Women In The US Are More Likely Than Men To Forgo Medicines Because Of Cost. Health Aff (Millwood). 2020 Aug;39(8):1334-1342. Read more
Hung YW, Law MR, Cheng L, Abramowitz S, Alcayna-Stevens L, Lurton G, Mayaka SM, Olekhnovitch R, Kyomba G, Ruton H, Ramazani SY, Grépin KA. Impact of a free care policy on the utilisation of health services during an Ebola outbreak in the Democratic Republic of Congo: an interrupted time-series analysis. BMJ Glob Health. 2020 Jul;5(7):e002119. Read more
Hung YW, Law MR, Cheng L, Abramowitz S, Alcayna-Stevens L, Lurton G, Mayaka SM, Olekhnovitch R, Kyomba G, Ruton H, Ramazani SY, Grépin KA. Impact of a free care policy on the utilisation of health services during an Ebola outbreak in the Democratic Republic of Congo: an interrupted time-series analysis. BMJ Glob Health. 2020 Jul;5(7):e002119. Read more
Laba TL, Cheng L, Worthington HC, McGrail KM, Chan FKI, Mamdani M, Law MR. What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan. Health Policy. 2020 May 23:S0168-8510(18)30587-6. Online ahead of print. Read more
Law MR, Chan FKI, Harrison M, Worthington HC. Impact of brand drug discount cards on private insurer, government and patient expenditures. CMAJ. 2019 Nov 11;191(45):E1237-E1241. Read more
Bolatova T, Law MR. Income-related disparities in private prescription drug coverage in Canada. CMAJ Open. 2019 Oct 11;7(4):E618-E623. Read more
Cassels A, Law MR. The impact of the introduction of a formulary into a large Canadian private drug plan: an interrupted time-series analysis. CMAJ Open. 2019 Jul 18;7(3):E472-E477. Read more
Laba TL, Cheng L, Kolhatkar A, Law MR. Cost-related nonadherence to medicines in people with multiple chronic conditions. Res Social Adm Pharm. 2019 Jun 20. [Epub ahead of print] Read more
Law MR, Cheng L, Worthington H, Majumdar SR, McGrail KM, Chan F, Laba TL, Mamdani M. Impact of a household-level deductible on prescription drug use among lower-income adults: a quasi-experimental study. CMAJ Open. 2019 Mar 29;7(1):E167-E173. Read more
Chan FKI, McGrail K, Majumdar SR, Law MR. Changes in employer-sponsored private health insurance among retirees in Ontario: a cross-sectional study. CMAJ Open. 2019 Jan 21;7(1):E15-E22. Read more